The SLE and LN market offers opportunities with the launch of 10 late-stage pipeline drugs improving safety and efficacy, contrasting with the current generic treatments. However, growth is challenged ...
A new study found that low levels of 25-Hydroxyvitamin D levels are associated with significantly higher mortality and ...
A new study explored molecules carried within blood exosomes to see if changes in fat metabolism contribute to lupus.
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...
Early and sustained adherence to antimalarials may help prevent RA and SLE disease flares, cardiovascular complications, and reduce future hospital use and costs.
Belimumab Monotherapy Matches Combination Therapy in SLE Patients with systemic lupus erythematosus who receive belimumab monotherapy show comparable remission rates and disease control to those who ...
Investigators studied GLP-1 receptor agonist use and renal and inflammatory outcomes among patients with systemic lupus erythematosus and type 2 diabetes mellitus.
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks its own healthy tissues. This condition can affect multiple organs, including ...
Systemic lupus erythematosus (SLE) is a multifaceted autoimmune condition that can affect virtually every organ system, including the gastrointestinal (GI) tract. GI involvement in SLE is ...
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease with a heterogeneous clinical presentation, ranging from mild cutaneous manifestations to severe organ damage. One of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results